Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

This study has been completed.
Sponsor:
Collaborator:
OSI Pharmaceuticals
Information provided by (Responsible Party):
Indiana University
ClinicalTrials.gov Identifier:
NCT01174043
First received: July 30, 2010
Last updated: August 7, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)